← All Resmed INC filings

Resmed INC Form 4 insider transactions

NYSE
RMD
Resmed INC
Form 4: ResMed CEO Michael Farrell Executes Stock Options and Sells Shares Under 10b5-1 Plan
ResMed's CEO, Michael J. Farrell, exercised stock options and sold shares of ResMed Common Stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
RMD
Resmed INC
Form 4: ResMed Director Carol Burt Reports Gift of Shares to Charity
Director Carol Burt reported a gift of ResMed shares to a charitable organization on April 29, 2024.
NYSE
RMD
Resmed INC
Form 4: ResMed Director Karen Drexler Sells 425 Shares of Common Stock
Director Karen Drexler sold 425 shares of ResMed Inc. common stock at a price of $214.92 on April 29, 2024.
NYSE
RMD
Resmed INC
Form 4: ResMed Inc. Executive Michael J. Rider Reports Stock Sale
Michael J. Rider, Global General Counsel of ResMed Inc., reports the sale of 81 shares of common stock at $180 per share.
NYSE
RMD
Resmed INC
Form 4: ResMed Inc. Executive Michael J. Rider Reports Stock Sale
Michael J. Rider, Global General Counsel of ResMed Inc., reports selling 200 shares of ResMed Common Stock on March 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.